The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 10, 2013

Filed:

Dec. 31, 2009
Applicants:

Arthur B. Raitano, Los Angeles, CA (US);

Pia M. Challita-eid, Encino, CA (US);

Aya Jakobovits, Beverly Hills, CA (US);

Mary Faris, Los Angeles, CA (US);

Wangmao GE, Culver City, CA (US);

Inventors:

Arthur B. Raitano, Los Angeles, CA (US);

Pia M. Challita-Eid, Encino, CA (US);

Aya Jakobovits, Beverly Hills, CA (US);

Mary Faris, Los Angeles, CA (US);

Wangmao Ge, Culver City, CA (US);

Assignee:

Agensys, Inc., Santa Monica, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/00 (2006.01); C12P 21/08 (2006.01); G01N 33/53 (2006.01); A61K 39/395 (2006.01); A61K 39/21 (2006.01);
U.S. Cl.
CPC ...
Abstract

A novel gene 251P5G2 and its encoded protein, and variants thereof, are described wherein 251P5G2 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 251P5G2 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 251P5G2 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 251P5G2 can be used in active or passive immunization.


Find Patent Forward Citations

Loading…